“Following the advisory committee’s favourable recommendation, the process now goes to the relevant global index body,” one of the people said. “Their product teams are working out modalities of facilitating inclusion by September or October.”
Market movement to be limited in coming quarter; be neutral on pharma: Amit Khurana
Amit Khurana of Dolat Capital anticipates limited market movement in the coming quarter due to headwinds, suggesting a cooling period before renewed buying. Upside potential
June 23, 2025